Home Americas Americas: Purdue University’s carcinogen research receives grant

Americas: Purdue University’s carcinogen research receives grant

A Purdue University health sciences professor received a US$1.68 million grant to study if a probable carcinogen formed when grilling meat at high temperatures also is a neurotoxin linked to Parkinson’s disease.

Jason Cannon, an associate professor of toxicology in the School of Health Sciences, received the five-year grant from the National Institute of Environmental Health Sciences.

“Other researchers have found that the class of compounds heterocyclic aromatic animes is probable carcinogens, and one of these cancer scientists shared with me that while the animals in their study were exposed to the carcinogen, they also experienced neurological problems,” said Cannon, who studies dietary toxins and neurological disease.

“My lab’s work has found that when we isolate neurons in cultures and expose cells to reasonable doses of these compounds, yes, we see the same types of neurons lost in Parkinson’s disease.”

Heterocyclic aromatic animes are found in many foods, but at especially high levels in meat cooked at high temperatures, such as grilling.

Cannon will study this compound’s effects more in depth in cell cultures and animal models to understand the molecular and biochemical mechanisms as well as the pathology.

His study also will look at gene environment interactions, as most cases of Parkinson’s disease are likely caused by genetic susceptibility and environmental exposures.

In Parkinson’s disease, dopaminergic neurons in one very small brain region are affected, though the disease affects many systems.

The disease affects more than one million Americans and causes people to lose motor function. Many other symptoms occur, such as sleep disorders, gastrointestinal dysfunction and speech impediments.

“Much of the toxicity research related to Parkinson’s disease focuses on exposure from pesticides or industry, but these exposures are likely pretty rare or at low doses for the average person,” Cannon said.

“We’re interested in looking at factors that people potentially encounter every day.”

Story by Amy Patterson Neubert, Purdue University

Previous articleEurope: Telepizza expands overseas with master franchise in Malta
Next articleAmericas: Avery Dennison expands PET-friendly label portfolio